Skip to main content
Contact Us
Subscribe
E-Edition
81°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by EDAP TMS S.A.
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
October 24, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces First Patients Treated in Phase I/II Study Evaluating Focal One Robotic HIFU for the Treatment of Benign Prostatic Hyperplasia (BPH)
October 01, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
September 19, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
August 29, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Reports Second Quarter 2024 Financial Results
August 28, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
August 07, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)
August 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
July 19, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Appoints Fran Schulz to Board of Directors
July 08, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
June 03, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP to Present at the Jefferies Global Healthcare Conference
May 22, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Reports First Quarter 2024 Financial Results
May 16, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
May 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
May 02, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
April 23, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
March 27, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
March 13, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
March 06, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
March 04, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
February 29, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
February 01, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
January 08, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
January 02, 2024
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
December 12, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
December 06, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
November 30, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
November 20, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP Announces Third Quarter 2023 Financial Results
November 09, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP to Present at the Jefferies London Healthcare Conference
November 06, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
October 26, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
Tickers
EDAP
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.